Dec 12 |
Lucid Diagnostics Announces Peer-Reviewed Publication of Positive Results from Three Clinical Utility Studies
|
Dec 11 |
PAVmed Provides Additional Details for Upcoming Stock Dividend to Shareholders
|
Dec 4 |
PAVmed announces dividend of Lucid Diagnostics shares and reverse stock split
|
Dec 4 |
PAVmed Announces Dividend of Lucid Diagnostics Common Stock and Reverse Stock Split
|
Nov 20 |
PAVmed Inc. (NASDAQ:PAVM) Q3 2023 Earnings Call Transcript
|
Nov 15 |
Lucid Diagnostics Inc. (LUCD) Q3 2023 Earnings Call Transcript
|
Nov 14 |
PAVmed Provides Business Update and Third Quarter Financial Results
|
Nov 14 |
Lucid Diagnostics Non-GAAP EPS of -$0.22 in-line, revenue of $0.8M beats by $0.01M
|
Nov 13 |
Lucid Diagnostics Provides Business Update and Third Quarter Financial Results
|
Nov 9 |
Lucid Diagnostics Launches Next-Generation EsoGuard® Esophageal DNA Test and Announces Upcoming Investor Day
|